These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 876471
21. The potential role of dopamine in the treatment of shock. Goldberg LI, Talley RC, McNay JL. Prog Cardiovasc Dis; 1969 Jul; 12(1):40-51. PubMed ID: 5807585 [No Abstract] [Full Text] [Related]
26. Mechanism of action of dopamine in endotoxin shock. Shanbour LL. J Okla State Med Assoc; 1970 Jan; 63(1):29-32. PubMed ID: 5511575 [No Abstract] [Full Text] [Related]
27. [Efficacy and limitations of dopamine in the treatment of acute circulatory insufficiency]. Pierri A, Costa PP, Piccinni P, Rodá M. Minerva Anestesiol; 1978 Jan; 44(7-8):533-42. PubMed ID: 683528 [No Abstract] [Full Text] [Related]
28. Dopamine and dopamine receptor agonists in cardiovascular therapy. Murphy MB, Elliott WJ. Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161 [Abstract] [Full Text] [Related]
29. [Renal and hemodynamic effects of dopamine in chronic heart failure]. Bianchi C, Beregovich J, Lewitt B. Rev Med Chil; 1974 Jun; 102(6):417-21. PubMed ID: 4471408 [No Abstract] [Full Text] [Related]
30. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Power DA, Duggan J, Brady HR. Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S23-8. PubMed ID: 10386250 [Abstract] [Full Text] [Related]
31. [Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis]. Mauro G, Cantino G, Vigiani L. Clin Ter; 1981 Mar 15; 96(5):515-21. PubMed ID: 7285521 [No Abstract] [Full Text] [Related]
32. [Failure of the peripheral circulation]. Wollheim E. Munch Med Wochenschr; 1967 Apr 07; 109(14):749-61. PubMed ID: 5631409 [No Abstract] [Full Text] [Related]
34. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents]. Lochner W. Arzneimittelforschung; 1970 Mar 07; 20():424-32. PubMed ID: 4989252 [No Abstract] [Full Text] [Related]
35. Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs. Prichard BN. Proc R Soc Med; 1969 Jan 07; 62(1):84-91. PubMed ID: 5763482 [No Abstract] [Full Text] [Related]
36. [Mode of action and possibilities of use of dopamine]. Weidner A. ZFA (Stuttgart); 1977 Jan 10; 53(1):35-42. PubMed ID: 842100 [No Abstract] [Full Text] [Related]
37. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Clin Pharmacol Ther; 1997 Aug 10; 62(2):187-93. PubMed ID: 9284855 [Abstract] [Full Text] [Related]
38. [The treatment of shock with isoproterenol]. Gigon JP, Wolff G, Enderlin F. Schweiz Med Wochenschr; 1966 May 07; 96(18):597-603. PubMed ID: 4296045 [No Abstract] [Full Text] [Related]
39. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Willems JL, Buylaert WA, Lefebvre RA, Bogaert MG. Pharmacol Rev; 1985 Jun 07; 37(2):165-216. PubMed ID: 2996038 [No Abstract] [Full Text] [Related]
40. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis]. Furukawa T. Saishin Igaku; 1965 Jul 07; 20(7):1743-58. PubMed ID: 5884753 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]